{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:48:59Z","timestamp":1785883739608,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST105-2320-B-038-049"],"award-info":[{"award-number":["MOST105-2320-B-038-049"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010613","name":"Taipei Medical University Hospital","doi-asserted-by":"publisher","award":["103TMU-TMUH-08"],"award-info":[{"award-number":["103TMU-TMUH-08"]}],"id":[{"id":"10.13039\/501100010613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.clinbiochem.2018.04.009","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T06:35:57Z","timestamp":1524206157000},"page":"75-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Elevated IgM against N\u03b5-(Carboxyethyl)lysine-modified Apolipoprotein A1 peptide 141\u2013147 in Taiwanese with Alzheimer's disease"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8269-797X","authenticated-orcid":false,"given":"Ching-Yu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jau-Jiuan","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Shih","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen-Te","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Uen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Wen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horng-Mo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Huei","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Kuo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ho","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3165-9177","authenticated-orcid":false,"given":"Yung-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2018.04.009_bb0005","series-title":"World Alzheimer Report 2016","author":"Prince","year":"2016"},{"issue":"6","key":"10.1016\/j.clinbiochem.2018.04.009_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100303","article-title":"A nationwide survey of mild cognitive impairment and dementia, including very mild dementia, in Taiwan","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clinbiochem.2018.04.009_bb0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jalz.2013.01.013","article-title":"The future of blood-based biomarkers for Alzheimer's disease","volume":"10","author":"Henriksen","year":"2014","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.clinbiochem.2018.04.009_bb0020","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3233\/JAD-130920","article-title":"Early molecular changes in Alzheimer disease: can we catch the disease in its presymptomatic phase?","volume":"38","author":"Wirz","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.clinbiochem.2018.04.009_bb0025","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1471-4159.2012.07845.x","article-title":"Huntingtin associated protein 1 regulates trafficking of the amyloid precursor protein and modulates amyloid beta levels in neurons","volume":"122","author":"Yang","year":"2012","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.clinbiochem.2018.04.009_bb0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neulet.2009.11.010","article-title":"Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells","volume":"468","author":"Su","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.clinbiochem.2018.04.009_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/238485","article-title":"Role of methylglyoxal in Alzheimer's disease","volume":"2014","author":"Angeloni","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.clinbiochem.2018.04.009_bb0040","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0002-9440(10)65659-3","article-title":"Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases","volume":"153","author":"Sasaki","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2018.04.009_bb0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.trsl.2011.12.004","article-title":"Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy","volume":"159","author":"Jack","year":"2012","journal-title":"Transl. Res."},{"issue":"1","key":"10.1016\/j.clinbiochem.2018.04.009_bb0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nbd.2009.09.008","article-title":"Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus","volume":"37","author":"Valente","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"4481","key":"10.1016\/j.clinbiochem.2018.04.009_bb0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.6779377","article-title":"Nonenzymatic browning in vivo: possible process for aging of long-lived proteins","volume":"211","author":"Monnier","year":"1981","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.clinbiochem.2018.04.009_bb0060","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.clinbiochem.2018.04.009_bb0065","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neurobiolaging.2003.11.001","article-title":"Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides","volume":"25","author":"Mruthinti","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.clinbiochem.2018.04.009_bb0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7555\/JBR.30.20150131","article-title":"Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications","volume":"30","author":"Wu","year":"2016","journal-title":"J. Biomed. Res."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2018.04.009_bb0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/prca.201200087","article-title":"Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration","volume":"7","author":"Keeney","year":"2013","journal-title":"Proteomics Clin. Appl."},{"issue":"1","key":"10.1016\/j.clinbiochem.2018.04.009_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0197-4580(99)00103-7","article-title":"Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease","volume":"21","author":"Merched","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.clinbiochem.2018.04.009_bb0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0009-8981(95)06115-T","article-title":"Marked decrease of plasma apolipoprotein AI and AII in Japanese patients with late-onset non-familial Alzheimer's disease","volume":"239","author":"Kawano","year":"1995","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2018.04.009_bb0090","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","year":"1994"},{"issue":"7","key":"10.1016\/j.clinbiochem.2018.04.009_bb0095","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.clinbiochem.2018.04.009_bb0100","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3233\/JAD-151068","article-title":"Apolipoprotein A1 in cerebrospinal fluid and plasma and progression to Alzheimer's disease in non-demented elderly","volume":"56","author":"Slot","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.clinbiochem.2018.04.009_bb0105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/01.wnl.0000172958.95282.2a","article-title":"The AD8: a brief informant interview to detect dementia","volume":"65","author":"Galvin","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.clinbiochem.2018.04.009_bb0110","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jprot.2015.05.038","article-title":"Analysis of differentially expressed novel post-translational modifications of plasma apolipoprotein E in Taiwanese females with breast cancer","volume":"126","author":"Uen","year":"2015","journal-title":"J. Proteome"},{"issue":"7","key":"10.1016\/j.clinbiochem.2018.04.009_bb0115","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1021\/pr200153k","article-title":"PeaksPTM: mass spectrometry-based identification of peptides with unspecified modifications","volume":"10","author":"Han","year":"2011","journal-title":"J. Proteome Res."},{"issue":"8","key":"10.1016\/j.clinbiochem.2018.04.009_bb0120","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1074\/mcp.M115.050518","article-title":"Development of diagnostic fragment ion library for glycated peptides of human serum albumin: targeted quantification in Prediabetic, diabetic, and microalbuminuria plasma by parallel reaction monitoring, SWATH, and MSE","volume":"14","author":"Korwar","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"10.1016\/j.clinbiochem.2018.04.009_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086564","article-title":"Perturbation of human coronary artery endothelial cell redox state and NADPH generation by methylglyoxal","volume":"9","author":"Morgan","year":"2014","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2018.04.009_bb0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1515\/DMDI.2008.23.1-2.151","article-title":"Free radical generation by methylglyoxal in tissues","volume":"23","author":"Desai","year":"2008","journal-title":"Drug Metabol. Drug Interact."},{"issue":"11","key":"10.1016\/j.clinbiochem.2018.04.009_bb0135","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.91.11.4766","article-title":"Advanced glycation end products contribute to amyloidosis in Alzheimer disease","volume":"91","author":"Vitek","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.clinbiochem.2018.04.009_bb0140","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.exger.2010.03.001","article-title":"Advanced glycation end products as biomarkers and gerontotoxins - a basis to explore methylglyoxal-lowering agents for Alzheimer's disease?","volume":"45","author":"Krautwald","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.clinbiochem.2018.04.009_bb0145","first-page":"191863","article-title":"The role of the blood-brain barrier in the pathogenesis of senile plaques in Alzheimer's disease","volume":"2014","author":"Provias","year":"2014","journal-title":"Int. J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.clinbiochem.2018.04.009_bb0150","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10571-015-0233-3","article-title":"Role of RAGE in Alzheimer's disease","volume":"36","author":"Cai","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.clinbiochem.2018.04.009_bb0155","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.neurobiolaging.2011.02.003","article-title":"AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation","volume":"33","author":"Li","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.clinbiochem.2018.04.009_bb0160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2796.2011.02411.x","article-title":"High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes","volume":"271","author":"Engelbertsen","year":"2012","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.clinbiochem.2018.04.009_bb0165","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bbrc.2011.03.040","article-title":"An autoantibody against N(epsilon)-(carboxyethyl)lysine (CEL): possible involvement in the removal of CEL-modified proteins by macrophages","volume":"407","author":"Mera","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.clinbiochem.2018.04.009_bb0170","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.59.3.378","article-title":"Serum lipoprotein levels, statin use, and cognitive function in older women","volume":"59","author":"Yaffe","year":"2002","journal-title":"Arch. Neurol."},{"issue":"12","key":"10.1016\/j.clinbiochem.2018.04.009_bb0175","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1021\/bi002186k","article-title":"Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits a beta aggregation and toxicity","volume":"40","author":"Koldamova","year":"2001","journal-title":"Biochemistry"},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2018.04.009_bb0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0304-3940(95)11565-7","article-title":"Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid","volume":"191","author":"Golabek","year":"1995","journal-title":"Neurosci. Lett."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201731216X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201731216X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:09:22Z","timestamp":1762114162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991201731216X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":36,"alternative-id":["S000991201731216X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.04.009","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated IgM against N\u03b5-(Carboxyethyl)lysine-modified Apolipoprotein A1 peptide 141\u2013147 in Taiwanese with Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}]}}